Cryopreservation – News and Features

A study by the University of Queensland identified inflammatory proteins, specifically elevated cytokines, in the blood of long COVID patients, which may explain persistent cardiovascular symptoms such as chest pain and heart palpitations.

A study from the Buck Institute reveals that threonine, an essential amino acid, could extend lifespan in both fruit flies and humans. By utilizing machine learning and systems biology, researchers linked key metabolites between species.

An international team has developed a new imaging method that analyzes cancer cells and their surrounding tissue at a single-cell level. This innovative approach identifies distinct patient groups based on prognosis.

Colossal reports significant advancements in thylacine de-extinction efforts, including the generation of the highest quality ancient genome and record-breaking multiplex genome editing.

Researchers found that specific genetic mutations in Black patients with acute myeloid leukemia (AML) significantly affect survival outcomes. Their findings stress the importance of including ancestry-specific factors in AML risk stratification.

A recent study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even death, for up to three years after diagnosis.

Researchers developed the DRIVE method, which analyzes shared segments of the genome to identify undiagnosed cases of Long QT syndrome. The study highlights the potential for better detection of rare genetic variants in larger populations.

A study has revealed two distinct molecular subtypes of Crohn’s disease using organoids from adult stem cells, allowing for better understanding of the disease's mechanisms. The findings suggest treatments should be tailored based on these subtypes.

A UCLA team created a biobank of sarcoma organoids from 126 patients, enabling rapid drug screening. The organoids retained tumor characteristics, allowing identification of effective FDA-approved treatments for 59% of samples.

People who consume a regular amount of flavonoid-rich food like berries, tea and red wine tend to have a lower risk of dementia, according to a new study.